Is Sprycel a chemotherapy drug?
Sprycel (dasatinib) is an oral anticancer targeted therapy classified as a BCR-ABL tyrosine kinase inhibitor (TKI) and is used to treat certain types of blood or bone marrow cancer. It is used in adults and children to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (Ph+ CML) or acute lymphoblastic leukemia (Ph+ ALL) in various phases.
Sprycel is given as an oral tablet taken by mouth. You do not receive this medicine as an injection. For some patients, Sprycel may be used in addition to chemotherapy.
The Philadelphia chromosome is a defective string of DNA that promotes the production of leukemia cells. Leukemia most often refers to cancer of the white blood cells, which are needed to help the immune system fight off disease and infection. Leukemia is either acute (occurs quickly) or chronic (occurs over a longer period). Leukemia is not thought to be an inherited disease through families, but some forms may be diagnosed in close family members.
Specifically, Sprycel is approved by the FDA to treat:
- adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
- adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib mesylate (Gleevec)
- adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatments
- children 1 year of age and older with Ph+ CML in chronic phase
- children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy
Which drugs are like Sprycel?
A list of BCR-ABL tyrosine kinase inhibitors includes:
- imatinib (Gleevec): first approved in 2001; used to treat ALL, CML, myelodysplastic diseases, dermatofibrosarcoma protuberan (a rare type of skin cancer), cutaneous mastocytosis, gastrointestinal stromal tumor.
- dasatinib (Sprycel): first approved in 2006; used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (Ph+ CML) or acute lymphoblastic leukemia (Ph+ ALL).
- nilotinib (Tasigna): first approved in 2007; used to treat Ph+ CML or ALL
- bosutinib (Bosulif) - first approved in 2012; used to treat Ph+ CML
- ponatinib (Iclusig) - first approved in 2012; used to treat CML, Ph+ ALL
Related questions
- Gleevec vs Sprycel vs Tasigna - how do they compare?
- How long does it take Sprycel (dasatinib) to start working?
- What is the strongest chemotherapy drug for breast cancer?
What are the most common side effects with Sprycel?
The most common side effects of Sprycel in adults and children receiving the medication as a single-agent therapy (occurring in at least 15% of patients) include:
- low blood cell counts (bone marrow suppression) - can also be a serious side effect
- fluid retention, swelling - can also be a serious side effect
- diarrhea
- headache
- skin rash
- hemorrhage (bleeding, blood loss) - can also be a serious side effect
- shortness of breath (dyspnea)
- fatigue
- nausea
- muscle and bone pain
Sprycel may also cause other serious side effects, such as:
- heart problems
- pulmonary arterial hypertension
- severe skin reactions
- tumor lysis syndrome
Important: See other side common and serious side effects related to Sprycel therapy. Talk to your doctor about these side effects, how to recognize them, and when to report them to a healthcare provider.
Does Sprycel cause hair loss (alopecia)?
Sprycel has been reported to cause hair loss (alopecia) in 1% to less than 10% of patients but is not listed as a common side effect. The manufacturer reported hair loss based on data gathered from 2,809 participants in pooled studies evaluating Sprycel use in chronic myeloid leukemia (CML) and adults in Ph+ ALL.
Sprycel may also rarely lead to changes in hair color (depigmentation). One case report in a 56 year old woman described depigmentation that began 2 months after Sprycel therapy was started for CML. Depigmentation worsened over 12 months, and was reversible 2 to 3 months after treatment was stopped. Hair loss was not specifically noted. Skin depigmentation on the face and trunk was also reported.
This is not all the information you need to know about Sprycel (dasatinib) for safe and effective use. Review the full Sprycel information here, and discuss this information and any questions you have with your doctor or other health care provider.
References
- Sprycel (dasatinib) [product information]. Bristol Myers Squibb. Princeton, NJ. Updated 12/2018. Accessed Feb. 12, 2021 at https://packageinserts.bms.com/pi/pi_sprycel.pdf
- Fujimi A, Ibata S, Kanisawa T, et al. Reversible skin and hair depigmentation during chemotherapy with dasatinib for chronic myeloid leukemia. Letter to the Editor. J Dermatol. 2016 Jan;43(1):106-7. doi:10.1111/1346-8138.13150. Epub 2015 Oct 5. PMID: 26434556.
- Leukemia. Harvard Health. Drugs.com. Accessed Feb 14, 2021 at https://www.drugs.com/health-guide/leukemia.html
Read next
Which medications make you sleepy?
Many medications can make you sleepy – some intentionally – such as sleeping pills, but others can make you tired as a side effect or an unintended consequence of the medication. It is important to know before taking a medication if there is a chance it may make you sleepy, drowsy, tired, or fatigued, because this may have an impact on your driving or ability to operate machinery, and how competent you are to make good decisions. 13 common classes of medications can make you sleepy. Continue reading
Is small cell or non-small cell lung cancer worse?
Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading
Is non-small cell lung cancer hereditary?
A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Timolol
Timolol is used for angina, heart attack, high blood pressure, migraine, migraine prevention
Valproic acid
Valproic acid is used for bipolar disorder, cluster-tic syndrome, epilepsy, headache ...
Divalproex sodium
Divalproex sodium is used for bipolar disorder, borderline personality disorder, cyclothymic ...
Topiramate
Learn about topiramate, an anticonvulsant used for seizures, migraine prevention, and weight loss ...
Related medical questions
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of prostate cancer is Erleada used to treat?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
- Oxycodone vs Hydrocodone - How do they compare?
- Does methylene blue kill cancer cells​?
- Does omeprazole cause cancer?
- Why is Xanax so addictive?
- Does Ozempic cause cancer?
- How do you increase platelet count during chemotherapy?
- Radiation vs. Chemo: Which cancer treatment is right for you?
- What are monoclonal antibodies?
- Vicodin vs Percocet: What's the difference?
- What is Quercetin and what are its health benefits?
- Why give Taxol (Paxel) before carboplatin?
- What is the TC chemo regimen and how does it treat breast cancer?
- What medications are known to cause hair loss?
- How do I know if immunotherapy is working?
- What are anti-VEGF drugs (VEGF inhibitors)?
- Treatments for Menopause
- My stool has changed color. What does it mean?
- How is Keytruda used for lung cancer?
- How do I know if Aldara is working for skin cancer?
- When is Keytruda used for prostate cancer?
Drug information
Related support groups
- Dasatinib (3 questions, 10 members)
- Sprycel (3 questions, 48 members)
- Cancer (195 questions, 645 members)
- Leukemia (16 questions, 79 members)
- Acute Lymphocytic Leukemia (4 questions, 9 members)
- Acute Lymphoblastic Leukemia (22 questions, 15 members)
- Chronic Myelogenous Leukemia (CML) (15 questions, 115 members)